Literature DB >> 6364236

Buspirone: an anxioselective alternative for the management of anxiety disorders.

L A Riblet, A S Eison, M S Eison, R E Newton, D P Taylor, D L Temple.   

Abstract

Buspirone HCl (Buspar) is a novel anxiolytic agent unrelated to the benzodiazepines or other psychotherapeutic agents. Animal studies support an anxioselective profile, i.e. relief of anxiety without sedation, muscle relaxation or anticonvulsant activity. Double-blind clinical studies show buspirone to be effective in the treatment of anxiety and anxiety in the presence of depression. The effects of buspirone on psychomotor function, physical dependence and abuse potential tests are similar to those seen with placebo treatments. Mechanism of action studies indicate activity in a variety of neuronal systems.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6364236     DOI: 10.1016/0278-5846(83)90042-8

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  3 in total

1.  The shock probe conflict procedure. A new assay responsive to benzodiazepines, barbiturates and related compounds.

Authors:  T F Meert; F C Colpaert
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Effect of HPMC and mannitol on drug release and bioadhesion behavior of buccal discs of buspirone hydrochloride: In-vitro and in-vivo pharmacokinetic studies.

Authors:  A Jaipal; M M Pandey; S Y Charde; P P Raut; K V Prasanth; R G Prasad
Journal:  Saudi Pharm J       Date:  2014-12-08       Impact factor: 4.330

3.  Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice.

Authors:  Jeon-Kyung Kim; Sang-Kap Han; Min-Kyung Joo; Dong-Hyun Kim
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.